Inventor
BACHMANN FELIX
CH19 patents
⚠️ This page may combine multiple inventors who share the name “BACHMANN FELIX”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BASILEA PHARMACEUTICA AG
8 patentsUS10067120B2Sep 4, 2018
Use of acetylated tubulin as a biomarker of drug response to furazanobenzimidazoles
BASILEA PHARMACEUTICA AG2 citations71
US9970938B2May 15, 2018
Use of BUBR1 as a biomarker of drug response to furazanobenzimidazoles
BASILEA PHARMACEUTICA AG2 citations69
USRE42890ENov 1, 2011
Furazanobenzimidazoles
BASILEA PHARMACEUTICA AG4 citations60
US7385061B2Jun 10, 2008
Furazanobenzimidazoles
BASILEA PHARMACEUTICA AG3 citations60
US10724072B2Jul 28, 2020
Use of phospho-Akt as a biomarker of drug response
BASILEA PHARMACEUTICA AG0 citations50
US10656162B2May 19, 2020
Use of glu-tubulin as a biomarker of drug response to furazanobenzimidazoles
BASILEA PHARMACEUTICA AG0 citations50
US7951957B2May 31, 2011
Substituted benzimidazoles and their use for inducing apoptosis
BASILEA PHARMACEUTICA AG0 citations49
US7423157B2Sep 9, 2008
Substituted benzimidazoles and their use for inducing apoptosis
BASILEA PHARMACEUTICA AG1 citations49
LANE HEIDI ALEXANDRA
5 patentsUS10006078B2Jun 26, 2018
Use of phospho-Akt as a biomarker of drug response
LANE HEIDI ALEXANDRA2 citations70
US9995754B2Jun 12, 2018
Use of glu-tubulin as a biomarker of drug response to furazanobenzimidazoles
LANE HEIDI ALEXANDRA2 citations70
US9366682B2Jun 14, 2016
Use of stathmin as a biomarker of drug response to furazanobenzimidazoles
LANE HEIDI ALEXANDRA3 citations70
US9476889B2Oct 25, 2016
Use of acetylated tubulin as a biomarker of drug response to furazanobenzimidazoles
LANE HEIDI ALEXANDRA2 citations59
US10222377B2Mar 5, 2019
Use of BUBR1 as a biomarker of drug response to furazanobenzimidazoles
LANE HEIDI ALEXANDRA0 citations47